New York Life Investment Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-22,508	Closed	-$327K	–	1320
2022 Q4	$327K	Buy	22,508 +2,535	+13%	+$36.8K	﹤0.01%	1107
2022 Q3	$381K	Buy	19,973 +1,467	+8%	+$28K	﹤0.01%	983
2022 Q2	$336K	Buy	+18,506	New	+$336K	﹤0.01%	1107